Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma

10.1080/02841860802637781

Saved in:

Bibliographic Details
Main Authors:	Chuah, B.Y.S., Yeo, W.-L., Guo, J.Y., Lim, S.-G., Yap, H.-L., Goh, B.-C., Lee, S.-C.
Other Authors:	CANCER SCIENCE INSTITUTE OF SINGAPORE
Format:	Article
Published:	2014
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/115788
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
by: Lee, S.-C., et al.
Published: (2012)

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
by: Jasinghe, V.J., et al.
Published: (2011)

BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients
by: Wanwisa Wongboonma, et al.
Published: (2018)

Discovery of benzimidazole derivatives as novel multi-target EGFR, VEGFR-2 and PDGFR kinase inhibitors
by: Li, Y., et al.
Published: (2014)

Novel VEGFR-2 kinase inhibitors identified by the back-to-front approach
by: Kingkan Sanphanya, et al.
Published: (2018)

Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas.
by: Shi, C.Y., et al.
Published: (2012)

BCR-ABL Tyrosine Kinase Domain Mutations Combinations Affects Imat inib Resistence in Chronic Phase Chronic Myelogenous Leukemia
by: Siprianus Ugroseno Yudho Bintoro, et al.
Published: (2019)

A customized mass array panel for BCR::ABL1 tyrosine kinase domain mutation screening in chronic myeloid leukemia
by: Limsuwanachot N.
Published: (2023)

Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma
by: Davids, M., et al.
Published: (2011)

Identification of Bruton tyrosine kinase mutations in 12 Chinese patients with X-linked agammaglobulinaemia by long PCR-direct sequencing
by: Chan, K.-W., et al.
Published: (2014)

PI3-kinase inhibition synergistically promoted the anti-tumor effect of lupeol in hepatocellular carcinoma
by: Liu F., et al.
Published: (2018)

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
by: Jin, S, et al.
Published: (2020)

The protein kinase CK2 catalytic domain from Plasmodium falciparum: Crystal structure, tyrosine kinase activity and inhibition
by: Ruiz-Carrillo, D, et al.
Published: (2020)

Butein, a specific protein tyrosine kinase inhibitor
by: Yang, E.-B., et al.
Published: (2013)

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma
by: Kan, Z., et al.
Published: (2014)

Lack of tyrosine nitration by hypochlorous acid in the presence of physiological concentrations of nitrite: Implications for the role of nitryl chloride in tyrosine nitration in vivo
by: Whiteman, M., et al.
Published: (2013)

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations
by: Costa D.B., et al.
Published: (2018)

Early detection of hepatocellular carcinoma
by: Kang, J.Y., et al.
Published: (2014)

Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer
by: Ju, Y.S, et al.
Published: (2020)

Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma
by: Mok, W.C., et al.
Published: (2014)

Inhibition of lymphocyte proliferation by sera from patients with hepatocellular carcinoma: Lack of correlation with serum alpha-fetoprotein levels
by: Ren, E.C., et al.
Published: (2016)

Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma
by: Fong, C.W., et al.
Published: (2014)

Catalytic activation of the membrane distal domain of protein tyrosine phosphatase ?, but not CD45, by two point mutations
by: Lim K.L., et al.
Published: (2018)

The protein kinase CK2 catalytic domain from Plasmodium falciparum : crystal structure, tyrosine kinase activity and inhibition
by: Ruiz-Carrillo, David, et al.
Published: (2018)

Ptb domain-directed substrate targeting in a tyrosine kinase from the unicellular choanoflagellate monosiga brevicollis
by: Prieto-Echagüe V., et al.
Published: (2019)

Differential expression of novel tyrosine kinase substrates during breast cancer development
by: Chen, Y., et al.
Published: (2012)

Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma
by: Huynh, H, et al.
Published: (2020)

Structure and physiology of the RET receptor tyrosine kinase
by: Ibáñez, C.F.
Published: (2016)

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
by: Xu, M.Z., et al.
Published: (2014)

Missense mutations in exons 18-24 of EGFR in hepatocellular carcinoma tissues
by: Ravat Panvichian, et al.
Published: (2018)

SPESIFIKASI TYROSIN KINASE SPERMATOZOA SAPI
by: NURYO.SEKARNOTO, 060112855
Published: (2005)

Hepatocellular carcinoma in Asia
by: Siddiqui, F.J., et al.
Published: (2014)

Time-resolved multimodal analysis of src homology 2 (SH2) domain binding in signaling by receptor tyrosine kinases
by: Jadwin, J.A, et al.
Published: (2020)

Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives
by: Yang, E.B., et al.
Published: (2014)

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: Its role in tumor progression and apoptosis
by: Huynh H., et al.
Published: (2018)

Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore
by: Shi, C.Y., et al.
Published: (2012)

Potential tripeptides against the tyrosine kinase domain of human epidermal growth factor receptor (HER) 2 through computational and kinase assay approaches
by: Supaphorn Seetaha, et al.
Published: (2020)

Familial primary hepatocellular carcinoma
by: Oon, C.J., et al.
Published: (2016)

Exploring age-dependent regulation of tyrosine hydroxylase in mice lacking the dopamine transporter.
by: Lim, Gerard Shing-Wan.
Published: (2010)

Inhibitors of the tyrosine kinase signaling cascade for asthma
by: Wong, W.S.F.
Published: (2012)